The Plasma Chromogranin A Level Predicts Survival and Tumor Response in Patients with Gastroenteropancreatic Neuroendocrine Tumors

被引：0
|
作者：
Chou, W. C. [1 ,2 ]
Chen, J. S. [1 ,2 ]
Hsu, J. T. [2 ,3 ]
Chen, T. C. [2 ,4 ]
Hung, Y. S. [1 ,2 ]
Sun, C. F. [2 ,5 ]
Hwang, T. L. [2 ,3 ]
机构：
[1] Chang Gung Mem Hosp, Div Hematol Oncol, Taoyuan, Taiwan
[2] Chang Gung Univ, Taoyuan, Taiwan
[3] Chang Gung Mem Hosp, Dept Surg, Taoyuan, Taiwan
[4] Chang Gung Mem Hosp, Dept Pathol, Taoyuan, Taiwan
[5] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan
来源：
NEUROENDOCRINOLOGY | 2014年 / 99卷 / 3-4期
关键词：
neuroendocrine tumor; biomarker; chromogranin a;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
H5
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [1] Plasma Chromogranin A Levels Predict Survival and Tumor Response in Patients with Advanced Gastroenteropancreatic Neuroendocrine Tumors
    Chou, Wen-Chi
    Chen, Jen-Shi
    Hung, Yu-Shin
    Hsu, Jun-Te
    Chen, Tse-Ching
    Sun, Chien-Feng
    Lu, Chang-Hsien
    Hwang, Tsann-Long
    [J]. ANTICANCER RESEARCH, 2014, 34 (10) : 5661 - 5669
  • [2] Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum
    Woltering, Eugene A.
    Beyer, David T.
    Thiagarajan, Ramcharan
    Ramirez, Robert A.
    Wang, Yi-Zarn
    Ricks, M. Jennifer
    Boudreaux, J. Philip
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 222 (04) : 534 - 542
  • [3] Plasma chromogranin A as marker for survival in patients with metastatic endocrine gastroenteropancreatic tumors
    Arnold, Rudolf
    Wilke, Alexandra
    Rinke, Anja
    Mayer, Christina
    Kann, Peter Herbert
    Klose, Klaus-Jochen
    Scherag, Andre
    Hahmann, Maik
    Mueller, Hans-Helge
    Barth, Peter
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2008, 6 (07) : 820 - 827
  • [4] Elevated Plasma Pancreastatin, but Not Chromogranin A, Predicts Survival in Neuroendocrine Tumors of the Duodenum Discussion
    Townsend, Courtney M.
    Evers, Mark
    Levine, Edward
    Meyers, Michael
    Perrier, Nancy
    Boudreaux, Philip
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2016, 222 (04) : 542 - 544
  • [5] Chromogranin A predicts survival for resected pancreatic neuroendocrine tumors
    Shanahan, Matthew A.
    Salem, Ahmed
    Fisher, Alexander
    Cho, Clifford S.
    Leverson, Glen
    Winslow, Emily R.
    Weber, Sharon M.
    [J]. JOURNAL OF SURGICAL RESEARCH, 2016, 201 (01) : 38 - 43
  • [6] The Role of Plasma Chromogranin A as Assessment of Treatment Response in Non-functioning Gastroenteropancreatic Neuroendocrine Tumors
    Kim, Moonjin
    Lee, Sujin
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Kang, Won Ki
    Kim, Seung Tae
    [J]. CANCER RESEARCH AND TREATMENT, 2016, 48 (01): : 153 - 161
  • [7] Baseline and dynamic plasma chromogranin A (CgA) level to predict clinical outcome and tumor response in Asian patients with gastroenteropancreatic neuroendocrine tumor (GEP-NET).
    Chou, Wen-Chi
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [8] Chromogranin A Is a Reliable Biomarker for Gastroenteropancreatic Neuroendocrine Tumors in an Asian Population of Patients
    Chou, Wen-Chi
    Hung, Yu-Shin
    Hsu, Jun-Te
    Chen, Jen-Shi
    Lu, Chang-Hsien
    Hwang, Tsann-Long
    Rau, Kun-Ming
    Yeh, Kun-Yun
    Chen, Tse-Ching
    Sun, Chien-Feng
    [J]. NEUROENDOCRINOLOGY, 2012, 95 (04) : 344 - 350
  • [9] Relationship Between Lanreotide Autogel, Chromogranin A and Progression-Free Survival in Patients With Gastroenteropancreatic Neuroendocrine Tumors
    Buil-Bruna, Nuia
    Dehez, Marion
    Manon, Amandine
    Thi Xuan Quyen Nguyen
    Troconiz, Inaki F.
    [J]. PANCREAS, 2016, 45 (03) : 472 - 473
  • [10] Chromogranin A as a Marker for Diagnosis, Treatment, and Survival in Patients With Gastroenteropancreatic Neuroendocrine Neoplasm
    Wang, Yu-hong
    Yang, Qiu-chen
    Lin, Yuan
    Xue, Ling
    Chen, Min-hu
    Chen, Jie
    [J]. MEDICINE, 2014, 93 (27)
12345